C3 and alpha 1-antitrypsin deficiency: Our findings indicated that deficiency in AAT results in a diminished capacity to inhibit the proteolytic processing of C3 to C3d, suggesting a potential role for complement activation in the pathogenesis of AATD-related disease [19].